The parafascicular thalamic nucleus but not the prefrontal cortex facilitates the nitric oxide/cyclic GMP pathway in rat striatum

Neuroscience

Volumn 91, Issue 1, 1999, Pages 51-58

  Consolo, S ^a   Cassetti, A ^a   Uboldi, M C ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

7 NINA; AMPA receptors; cGMP release in vivo; Microdialysis in vivo; NMDA receptors; ODQ

Indexed keywords

1,2,4 OXADIAZOLE DERIVATIVE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 7 NITROINDAZOLE; AMPA RECEPTOR; CYCLIC GMP; DIZOCILPINE MALEATE; GUANYLATE CYCLASE INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; ENZYME ACTIVATION; ENZYME INHIBITION; INFORMATION PROCESSING; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; THALAMUS NUCLEUS;

ANIMALS; CYCLIC GMP; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; GUANYLATE CYCLASE; INDAZOLES; MALE; MICRODIALYSIS; NEOSTRIATUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PREFRONTAL CORTEX; RATS; RATS, INBRED STRAINS; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; TETRODOTOXIN; THALAMIC NUCLEI;

EID: 0032903144     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00601-0     Document Type: Article

References (52)

1. Ariano M. J. Distribution of components of the guanosine 3′,5′-phosphate system in rat caudate-putamen. Neuroscience. 10:1983;707-723.
2. Ariano M. J., Lewicki J. A., Brandwein H. J., Murad F. Immunohistochemical localization of guanylate cyclase within neurons of rat brain. Proc. natn. Acad. Sci. U.S.A. 79:1982;1316-1320.
3. Augood S. J., McGowan E. M., Emson P. C. Expression of N-methyl-D-aspartate receptor subunit NR1 messenger RNA by identified striatal somatostatin cells. Neuroscience. 59:1994;7-12.
4. Baldi G., Russi G., Nannini L., Vezzani A. Trans-synaptic modulation of striatal ACh Release in vivo by the parafascicular thalamic nucleus. Eur. J. Neurosci. 7:1995;1117-1180.
5. Bernard V., Normand E., Bloch B. Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J. Neurosci. 12:1992;3591-3600.
6. Billiar T. R., Curran R. D., Harbrecht B. G., Stadler J., Williams D. L., Ochoa J. B., Di Silvio M., Simmons R. L., Murray S. A. Association between synthesis and release of cGMP and nitric oxide biosynthesis by hepatocytes. Am. J. Physiol. 262:1992;1077-1082.
7. Boulton C. L., Southam E., Garthwaite J. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience. 69:1995;699-703.
8. Bredt D. S., Snyder S. H. Isolation of nitric oxide synthase, a calmodulin requiring enzyme. Proc. natn. Acad. Sci. U.S.A. 87:1990;682-685.
9. Cherubini E., Herrling P. L., Lanfumey L., Stanzione P. Excitatory amino acids in synaptic excitation of the striatal neurons in vitro. J. Physiol., Lond. 400:1988;677-690.
10. Consolo S., Baldi G., Giorgi S., Nannini L. Cerebral cortex and parafascicular nucleus facilitate striatal in vivo ACh release through distinct glutamate receptor subtypes. Eur. J. Neurosci. 8:1996;2702-2710.
11. Consolo S., Baronio P., Guidi G., Di Chiara G. Role of the parafascicular thalamic nucleus and N-methyl-D-aspartate transmission in the D1 dependent control of in vivo acetylcholine release in rat striatum. Neuroscience. 71:1996;157-165.
12. Dawson T. M., Bredt D. S., Fotuhi M., Hwang P. M., Snyder S. H. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc. natn. Acad. Sci. U.S.A. 88:1991;7797-7801.
13. Dubè L., Smith A. D., Bolam J. P. Identification of synaptic terminals of thalamic or cortical origin in contact with distinct medium-size spiny neurons in rat neostriatum. J. comp. Neurol. 267:1988;455-471.
14. East S. J., Garthwaite J. NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the L-arginine-nitric oxide pathway. Neurosci. Lett. 123:1991;17-19.
15. Fedele E., Jin Y., Varnier G., Raiteri M. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway. Br. J. Pharmac. 119:1996;590-594.
16. Figueredo-Cardenas G., Morello M., Sancesario G., Bernardi G., Reiner A. Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats. Brain Res. 735:1996;317-324.
17. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14:1991;60-67.
18. Garthwaite J., Garthwaite G., Palmer R. M. J., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmac. 172:1989;413-416.
19. Garthwaite J., Southam E., Boulton C. L., Nielsen E. B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]-oxadiazolo-[4,3-a]-quinoxalin-1-one. Molec. Pharmac. 48:1995;184-188.
20. Giorgi S., Rimoldi M., Rossi A., Consolo S. The parafascicular thalamic nucleus modulates messenger RNA encoding glutamate decarboxylase 67 in rat striatum. Neuroscience. 80:1997;793-801.
21. Goy M. F. cGMP: the wayward child of the cyclic nucleotide family. Trends Neurosci. 14:1991;293-298.
22. Hawkins R. D. NO honey, I don't remember. Neuron. 16:1996;465-467.
23. Herrling P. L. Pharmacology of the corticocaudate excitatory postsynaptic potential in the cat: evidence for its mediation by quisqualate or kainate receptors. Neuroscience. 14:1985;417-426.
24. Kachidian P., Vuillet J., Nieoullon A., Lafaille G., Kerkerian-Le Goff L. Striatal neuropeptide Y neurones are not a target of thalamic afferent fibers. NeuroReport. 7:1996;1665-1669.
25. Kapoor C. L., Krishna G. Hormone-induced cyclic guanosine monophosphate secretion from guinea pig pancreatic lobules. Science. 196:1977;1003-1005.
26. Kita H. Glutamatergic and GABAergic postsynaptic responses of striatal spiny neurons to intrastriatal and cortical stimulation recorded in slice preparations. Neuroscience. 70:1996;925-940.
27. Knowles R. G., Palacios M., Palmer R. M. J., Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. natn. Acad. Sci. U.S.A. 86:1989;5159-5162.
28. Kubota Y., Mikawa S., Kawaguchi Y. Neostriatal GABAergic interneurones contain NOS, calretinin or parvalbumin. NeuroReport. 5:1993;205-208.
29. Landwehrmeyer G. B., Standaert D. G., Testa C. M., Penney J. B., Young A. B. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 15(7):1995;5297-5307.
30. Lees G. J., Leong W. NBQX prevents contralateral but not ipsilateral seizure-induced cytotoxicity of kainate but not AMPA-reversal at high doses of NBQX. NeuroReport. 5:1994;2153-2156.
31. Lehmann J., Schneider J., McPherson S., Murphy D. E., Bernard P., Tsai C., Bennet D. A., Pastor G., Steel D. J., Bohem C., Cheney D. L., Liebman J. M., Williams M., Wood P. L. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. J. Pharmac. exp. Ther. 240:1987;737-746.
32. Luo D., Leung E., Vincent S. R. Nitric oxide-dependent efflux of cGMP in rat cerebellar cortex: an in vivo microdialysis study. J. Neurosci. 14:1994;263-271.
33. MacDermott A. B., Dale N. Receptors, ion channels and synaptic potentials underlying the integrative actions of excitatory amino acids. Trends Neurosci. 10:1987;280-284.
34. Massieu L., Tapia R. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline protects against both AMPA and kainate-induced lesions in rat striatum in vivo. Neuroscience. 59:1994;931-938.
35. Matsuoka I., Giuili G., Poyard M., Stengel D., Parma J., Guellaen G., Hanoune J. Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: comparison with calmodulin mRNA distribution. J. Neurosci. 12:1992;3350-3360.
36. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic, Sydney.
37. Phillips A. G., Fibiger H. C. The role of dopamine in mantaining intracranial self-stimulation in tha ventral tegmentum nucleus accumbens, and medial prefrontal cortex. Can. J. Psychol. 32:1978;58-66.
38. Schini V., Schoeffter P., Miller R. C. Effect of endothelium on basal and on stimulated accumulation and efflux of cyclic GMP in rat isolated aorta. Br. J. Pharmac. 97:1989;853-865.
39. Sheardown M. J., Nielsen E. O., Hansen A. J., Jacobsen P., Honoré T. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)-quinoxaline: a neuroprotectant for cerebral ischemia. Science. 247:1990;571-574.
40. Streit P. Selective retrograde labelling indicating the transmitter of neuronal pathways. J. comp. Neurol. 191:1980;429-463.
41. Taber M. T., Fibiger H. C. Cortical regulation of acetylcholine release in rat striatum. Brain Res. 639:1994;354-356.
42. Tallaksen-Greene S. J., Albin R. L. Localization of AMPA-selective excitatory amino acid receptor subunits in identified populations of striatal neurons. Neuroscience. 61:1994;509-519.
43. Tsou K., Snyder G. L., Greengard P. Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, in the substantia nigra. Proc. natn. Acad. Sci. U.S.A. 90:1993;3462-3465.
44. Vallebuona F., Raiteri M. Extracellular cGMP in the hippocampus of freely moving rats as an index of nitric oxide (NO) synthase activity. J. Neurosci. 14:1994;134-139.
45. Vallebuona F., Raiteri M. Age-related changes in the NMDA receptor/nitric oxide/cGMP pathway in the hippocampus and cerebellum of freely moving rats subjected to transcerebral microdialysis. Eur. J. Neurosci. 7:1995;694-701.
46. Vincent S. R., Johansson O., Hokfelt T., Skirboll L., Elde R. P., Terenius L., Kimmel J., Goldstein M. NADPH-diaphorase: a selective histochemical marker for striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities. J. comp. Neurol. 217:1983;252-263.
47. Vuillet J., Dimova R., Nieoullon A., Kerkerian-Le Goff L. Ultrastructural relationship between choline acetyltransferase and neuropeptide Y-containing neurons in the rat striatum. Neuroscience. 46:1992;351-360.
48. Vuillet J., Kerkerian-Le Goff L., Kachidian P., Bosler O., Nieoullon A. Ultrastructural correlates of functional relationships between nigral dopaminergic or cortical afferent fibers and neuropeptide Y-containing neurons in the rat striatum. Neurosci. Lett. 100:1989;99-104.
49. Vuillet J., Kerkerian-Le Goff L., Kachidian P., Dusticier G., Bosler O., Nieoullon A. Striatal NPY-containing neurons receive GABAergic afferents and may also contain GABA: an electron microscopic study in the rat. Eur. J. Neurosci. 2:1990;672-681.
50. Vuillet J., Kerkerian-Le Goff L., Kachidian P., Salin P., Nieoullon A. Ultrastructural features of NPY-containing neurons in the rat striatum. Brain Res. 477:1989;241-251.
51. Wang X., Robinson P. J. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J. Neurochem. 68:1997;443-456.
52. Wong E. F. H., Kemp J. A., Priestley T., Knight A. R., Woodruff G. N., Iversen L. L. The anticonvulsivant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. natn. Acad. Sci. U.S.A. 83:1986;7104-7108.